Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.
 

RSS icon
Thumbnail

Psychologist uses beta-blockers to ease patients’ emotional pain

A Canadian clinical psychologist is repurposing a beta-blocker to ease the pain of emotional trauma, the BBC reports.

Thumbnail

Diabetes drug rosiglitazone linked—again—to poor CV health

Research out of the Yale School of Public Health in New Haven, Conn., has revealed a relationship between rosiglitazone, a type 2 diabetes drug, and heart disease.

Thumbnail

FDA grants breakthrough status to pulmonary hypertension solution

The U.S. FDA on Feb. 6 granted Breakthrough Device Designation to medical device developer Aria CV, Inc., for its Aria CV Pulmonary Hypertension System.

Initiating antihypertensives, statins increases likelihood of obesity

People who begin taking antihypertensive drugs or lipid-lowerers like statins are more likely than non-initiators to become obese and physically inactive, a JAHA study has found—but they’re also more likely to quit smoking and keep their alcohol intake in check.

Thumbnail

BP variability in young adulthood linked to CV ills later in life

Higher visit-to-visit systolic blood pressure variability early in life may predict CVD and all-cause mortality in middle age, according to research published in JAMA Cardiology on Jan. 22. 

Thumbnail

Following controversial guideline, another study connects meat consumption to CVD

Another study has surfaced suggesting that meat—both processed and unprocessed—can have deleterious effects on heart health.

Why VA physicians are writing ‘farmacy’ prescriptions for food, not meds

Patients in Massachusetts may soon be receiving “farmacy” prescriptions in lieu of traditional pharmacy scripts.

Thumbnail

Antihypertensive drug amlodipine lowers long-term risk of gout

A large-scale study published in the Journal of Hypertension Jan. 20 suggests the calcium channel blocker amlodipine can lower hypertensive patients’ BP while simultaneously minimizing their long-term risk of developing gout.

Displaying 561 - 568 of 1158

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.